- Potential benefitReasserts Congressional oversight over major health program rules through the Congressional Review Act.
- ConsumersPrevents CMS changes supporters argue could increase consumer premiums or reduce marketplace subsidies.
- Potential benefitMaintains existing regulatory baseline, avoiding immediate administrative changes for insurer compliance.
Disapprove HHS 2027 ACA Benefit and Payment Rule
Referred to the House Committee on Energy and Commerce.
Congress is using the Congressional Review Act to overturn a final rule issued by HHS/CMS concerning the Notice of Benefit and Payment Parameters for 2027 and the Basic Health Program. The resolution would nullify that rule and, if enacted, would prevent the agency from issuing a substantially similar rule without new legislation. The CRA provides an expedited process in the Senate and allows Congress to disapprove a rule by simple majority.
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (91 Fed. Reg. 29526 (May 20, 2026)).
Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS)
Under the Congressional Review Act, the Senate may consider this disapproval under expedited procedures that prevent a filibuster and allow passage by a simple majority; both chambers must pass the joint resolution and the President must sign it to nullify the rule. A presidential veto could be overridden only by the required congressional majority.
This joint resolution invokes the Congressional Review Act to disapprove a Centers for Medicare & Medicaid Services rule titled "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program" (91 Fed.
Reg. 29526, May 20, 2026).
If enacted, the resolution would render that CMS rule null and void and prevent it from taking effect.
Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing under CRA rules.
Relative to its intended legislative type, this bill is a straightforward Congressional Review Act disapproval resolution that unambiguously identifies the administrative rule and declares it to have no force or effect.
Progressives emphasize preserving ACA implementation and consumer protections.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesBlocks CMS updates that may have been intended to stabilize premiums or reduce federal costs.
- StatesCreates uncertainty for insurers and states that were planning for 2027 parameters announced in the rule.
- ConsumersMay prevent adoption of consumer protections or coverage-expanding provisions included in the rescinded rule.
Why the argument around this bill splits.
Progressives emphasize preserving ACA implementation and consumer protections.
Likely opposed to the joint resolution because it would nullify an HHS rule implementing Affordable Care Act parameters and Basic Health Program provisions.
Democrats and progressives generally favor preserving regulatory protections and coverage-supporting rules absent clear harm.
Mixed view: sees procedural legitimacy in using the CRA, but worries about operational disruption without clear, specific justification.
Would weigh demonstrated fiscal and beneficiary impacts before supporting disapproval.
Likely supportive of disapproval, viewing it as a check on federal regulatory expansion under the ACA and a way to curb HHS rulemaking authority.
Prefers limiting federal mandates and promoting state control.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing under CRA rules.
- Which party or coalition controls each chamber during consideration
- Whether the CRA 60-legislative-day window for disapproval remains valid
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize preserving ACA implementation and consumer protections.
Narrow and procedurally simple but touches a highly contentious federal health policy; success hinges on chamber majorities and timing unde…
Relative to its intended legislative type, this bill is a straightforward Congressional Review Act disapproval resolution that unambiguously identifies the administrative rule and declares it to have no force or effect.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.